Skip to main content

Published locations for FDA approves ibrutinib for refractory MZL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves ibrutinib for refractory MZL

User login

  • Reset your password
  • /content/fda-approves-ibrutinib-refractory-mzl
  • /hematologynews/article/129678/indolent-lymphoma/fda-approves-ibrutinib-refractory-mzl
  • /oncologypractice/article/129678/indolent-lymphoma/fda-approves-ibrutinib-refractory-mzl
  • /hematologynews/nhlhub/article/129678/indolent-lymphoma/fda-approves-ibrutinib-refractory-mzl
  • /hematology-oncology/article/129678/indolent-lymphoma/fda-approves-ibrutinib-refractory-mzl